Iluvien shows similar reduction in DR progression as anti-VEGF treatment

LAS VEGAS β€” Fluocinolone acetonide and anti-VEGF treatment similarly reduce progression of proliferative diabetic retinopathy, according to a presentation here.β€œThe duration of continuous steroid exposure during the FAME trials provides a unique opportunity to address the clinical question of the impact of corticosteroids on progression of proliferative diabetic retinopathy (PDR),” Charles C. Wykoff, MD, PhD, said at Retina Subspecialty Day preceding the American Academy of Ophthalmology annual meeting.

Full Story β†’